M&A Deal Summary

Solar Biotech Acquires Eleszto Genetika

On January 23, 2025, Solar Biotech acquired life science company Eleszto Genetika

Acquisition Highlights
  • This is Solar Biotech’s 2nd transaction in the Life Science sector.
  • This is Solar Biotech’s 1st transaction in Hungary.

M&A Deal Summary

Date 2025-01-23
Target Eleszto Genetika
Sector Life Science
Buyer(s) Solar Biotech
Deal Type Merger

Target

Eleszto Genetika

Budapest, Hungary
Eleszto Genetika is providing service for microbial synthetic biology including pathway design, strain construction, screening, stirred tank fermentation process development and DSP process development in yeast. Eleszto Genetika was founded in 2007 and is based in Budapest, Hungary.

Search 204,782 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Solar Biotech

Norton, Virginia, United States

Category Company
Sector Life Science
DESCRIPTION

Solar Biotech is a SynBio product and advanced bioprocessing technology development company with a mission to transform the way consumer products are manufactured via advanced bioprocessing technologies, including precision fermentation. The research and development and biomanufacturing facility in Norton, Virginia, has facilitated over the past years the successful introduction of several major products to the SynBio food and beverage and other market segments. Solar Biotech is based in Norton, Virginia.


DEAL STATS #
Overall 3 of 3
Sector (Life Science) 2 of 2
Type (Merger) 2 of 2
Country (Hungary) 1 of 1
Year (2025) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-01-23 GPC Bio

Perigny, France

GPC Bio specializes in designing, manufacturing, and supporting advanced bioreactors and fermenters for small-to-medium-sized biotech companies. GPC Bio was founded in 2008 and is based in Perigny, France.

Buy -